Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review

Detalles Bibliográficos
Autores principales: Vender, Ronald, Turchin, Irina, Lansang, Perla, Prajapati, Vimal H., Legault, Mark, Barakat, Maxime, Yeung, Jensen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204718/
https://www.ncbi.nlm.nih.gov/pubmed/35721301
http://dx.doi.org/10.1016/j.jdin.2022.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204718/
https://www.ncbi.nlm.nih.gov/pubmed/35721301
http://dx.doi.org/10.1016/j.jdin.2022.05.001

Ejemplares similares